Find clinical trials in your area
Search by disease and location to discover available clinical trials matching your criteria.
↓
Matched clinical trials
Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer
Not recruiting
Investigated diseases:Investigated drugs:
+5
Study of Patritumab Deruxtecan for Patients with Brain Metastases from Advanced Breast or Lung Cancer and Leptomeningeal Disease from Solid Tumors
Not recruiting
Investigated diseases:Investigated drugs:
Study of Avutometinib, Sotorasib, and Defactinib for Patients with KRAS G12C Mutant Non-Small Cell Lung Cancer
Not recruiting
Investigated diseases:Investigated drugs:
Study on Brigatinib and Durvalumab for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with ALK Gene Change After Chemotherapy and Radiation Therapy
Not recruiting
Investigated diseases:Investigated drugs:
Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer
Not recruiting
Investigated drugs:
+6
Study on JDQ443 for Patients with KRAS G12C+ Non-Small Cell Lung Cancer and Brain Metastases
Not recruiting
Investigated diseases:Investigated drugs:
Study Comparing Zimberelimab and Domvanalimab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated diseases:Investigated drugs:
Study of Immunotherapy Combinations Including Zimberelimab for Patients With Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated diseases:Investigated drugs:
Study of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Not recruiting
Investigated diseases:Investigated drugs:
+4